Real-time enrollment status for this ductal carcinoma in situ clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:51 PM UTC
| NCT Number | NCT04985032 |
| Recruiting Status | Recruiting |
| Condition | Ductal Carcinoma in Situ |
| Phase | Clinical Trial |
| Target Enrollment | 200 participants |
| Active Locations | 2 sites in the US |
| Sponsor | RPCR, Inc. |
| Last Updated on CT.gov | August 5, 2022 (Aug 5, 2022) |
As of July 13, 2026: Clinical trial NCT04985032 is currently recruiting participants. This clinical trial study for ductal carcinoma in situ is actively seeking new participants at 2 locations across the United States. The study is sponsored by RPCR, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04985032 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04985032 was last updated Aug 5, 2022 (August 5, 2022). HelloStudys verifies this status automatically.